Collaboration with STEMCELL Technologies on Research-Use-Only System to Fuel Preclinical Research
WATERTOWN, Mass.–SQZ Biotechnologies (NYSE: SQZ) announced today that the company will present data from the first non-clinical studies of its point-of-care (POC) manufacturing system at the 2022 American Society for Gene… Read More




